PortfoliosLab logoPortfoliosLab logo
SNY vs. OMC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SNY vs. OMC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sanofi (SNY) and Omnicom Group Inc. (OMC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SNY achieves a -1.94% return, which is significantly higher than OMC's -5.81% return. Over the past 10 years, SNY has outperformed OMC with an annualized return of 5.12%, while OMC has yielded a comparatively lower 2.46% annualized return.


SNY

1D
1.44%
1M
3.95%
YTD
-1.94%
6M
-4.06%
1Y
-5.85%
3Y*
0.15%
5Y*
1.27%
10Y*
5.12%

OMC

1D
-0.42%
1M
-2.27%
YTD
-5.81%
6M
4.59%
1Y
9.58%
3Y*
-3.51%
5Y*
1.63%
10Y*
2.46%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SNY vs. OMC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SNY
Sanofi
-1.94%4.93%1.09%6.55%0.57%7.00%0.39%20.47%6.06%9.96%
OMC
Omnicom Group Inc.
-5.81%-2.62%2.49%9.57%15.72%21.88%-19.58%14.37%3.94%-11.93%

Correlation

The correlation between SNY and OMC is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Jul 2, 2002

0.33

The correlation between SNY and OMC shifts across timeframes, from 0.22 (10 years) to 0.33 (all time), reflecting how their relationship changes across market environments.

Fundamentals

EPS

SNY:

$3.09

OMC:

$0.51

PE Ratio

SNY:

14.58

OMC:

146.63

PS Ratio

SNY:

2.33

OMC:

0.57

Total Revenue (TTM)

SNY:

$47.35B

OMC:

$19.82B

Gross Profit (TTM)

SNY:

$34.18B

OMC:

$3.45B

EBITDA (TTM)

SNY:

$12.63B

OMC:

$1.14B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SNY vs. OMC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SNY
SNY Risk / Return Rank: 3131
Overall Rank
SNY Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
SNY Sortino Ratio Rank: 2828
Sortino Ratio Rank
SNY Omega Ratio Rank: 2929
Omega Ratio Rank
SNY Calmar Ratio Rank: 3333
Calmar Ratio Rank
SNY Martin Ratio Rank: 3232
Martin Ratio Rank

OMC
OMC Risk / Return Rank: 5252
Overall Rank
OMC Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
OMC Sortino Ratio Rank: 4949
Sortino Ratio Rank
OMC Omega Ratio Rank: 4848
Omega Ratio Rank
OMC Calmar Ratio Rank: 5656
Calmar Ratio Rank
OMC Martin Ratio Rank: 5757
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SNY vs. OMC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Omnicom Group Inc. (OMC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SNYOMCDifference
Sharpe ratioReturn per unit of total volatility

-0.51

Sortino ratioReturn per unit of downside risk

-0.82

Omega ratioGain probability vs. loss probability

0.99

1.09

-0.10

Calmar ratioReturn relative to maximum drawdown

-0.27

0.65

-0.92

Martin ratioReturn relative to average drawdown

-0.53

1.48

-2.01

SNY vs. OMC - Sharpe Ratio Comparison

The current SNY Sharpe Ratio is -0.18, which is lower than the OMC Sharpe Ratio of 0.33. The chart below compares the historical Sharpe Ratios of SNY and OMC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SNYOMCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.18

0.33

-0.51

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.05

0.06

-0.01

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.22

0.09

+0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

0.21

0.42

-0.21

Drawdowns

SNY vs. OMC - Drawdown Comparison

The maximum SNY drawdown since its inception was -46.46%, smaller than the maximum OMC drawdown of -61.22%. Use the drawdown chart below to compare losses from any high point for SNY and OMC.


Loading charts...

Drawdown Indicators


SNYOMCDifference

Max Drawdown

Largest peak-to-trough decline

-46.46%

-61.22%

+14.76%

Max Drawdown (1Y)

Largest decline over 1 year

-16.70%

-17.85%

+1.15%

Max Drawdown (3Y)

Largest decline over 3 years

-23.37%

-33.30%

+9.93%

Max Drawdown (5Y)

Largest decline over 5 years

-33.52%

-33.30%

-0.22%

Max Drawdown (10Y)

Largest decline over 10 years

-33.52%

-43.21%

+9.69%

Current Drawdown

Current decline from peak

-16.49%

-24.59%

+8.10%

Average Drawdown

Average peak-to-trough decline

-12.19%

-12.93%

+0.74%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.49%

7.76%

+0.73%

Volatility

SNY vs. OMC - Volatility Comparison

The current volatility for Sanofi (SNY) is 7.29%, while Omnicom Group Inc. (OMC) has a volatility of 9.53%. This indicates that SNY experiences smaller price fluctuations and is considered to be less risky than OMC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SNYOMCDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.29%

9.53%

-2.24%

Volatility (6M)

Calculated over the trailing 6-month period

15.76%

27.55%

-11.79%

Volatility (1Y)

Calculated over the trailing 1-year period

25.43%

34.75%

-9.32%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.77%

28.73%

-3.96%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.46%

28.73%

-5.27%

Dividends

SNY vs. OMC - Dividend Comparison

SNY's dividend yield for the trailing twelve months is around 5.38%, more than OMC's 3.98% yield.


PositionTTM20252024202320222021202020192018201720162015
OMC
Omnicom Group Inc.
3.98%3.59%3.25%3.24%3.43%3.82%4.17%3.21%3.28%3.09%2.53%2.64%
SNY
Sanofi
5.38%4.56%4.22%3.83%4.32%3.80%3.61%3.47%4.29%3.82%4.11%3.77%

Financials

SNY vs. OMC - Financials Comparison

This section allows you to compare key financial metrics between Sanofi and Omnicom Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


4.00B6.00B8.00B10.00B12.00B14.00B20222023202420252026
11.24B
6.24B
(SNY) Total Revenue
(OMC) Total Revenue
Values in USD except per share items

SNY vs. OMC - Profitability Comparison

The chart below illustrates the profitability comparison between Sanofi and Omnicom Group Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20222023202420252026
72.1%
16.6%
Portfolio components
SNY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sanofi reported a gross profit of 8.11B and revenue of 11.24B. Therefore, the gross margin over that period was 72.1%.

OMC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Omnicom Group Inc. reported a gross profit of 1.04B and revenue of 6.24B. Therefore, the gross margin over that period was 16.6%.

SNY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sanofi reported an operating income of 2.27B and revenue of 11.24B, resulting in an operating margin of 20.2%.

OMC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Omnicom Group Inc. reported an operating income of 646.20M and revenue of 6.24B, resulting in an operating margin of 10.4%.

SNY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sanofi reported a net income of 1.61B and revenue of 11.24B, resulting in a net margin of 14.4%.

OMC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Omnicom Group Inc. reported a net income of 418.70M and revenue of 6.24B, resulting in a net margin of 6.7%.


Frequently Asked Questions


SNY and OMC have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OMC has higher volatility (9.53%) compared to SNY (7.29%). In terms of maximum drawdown, SNY dropped -46.46% vs OMC's -61.22%.

OMC currently has the higher Sharpe Ratio (0.33 vs -0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SNY and OMC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer